Galderma’s Cetaphil is launching its Skin Activator Hydrating & Firming line.

Cetaphil is partnering with actress, director, and advocate Mariska Hargitay. As the face of the campaign, she will help share a message of empowerment and reinvention across public relations, advertising, in-store, retailer e-commerce, and social platforms.

The line aims to improve the appearance of aging, thinning, and fragile skin. It is powered by encapsulated centella asiatica (CICA) to help restore the skin’s moisture barrier and microdosed mandelic acid to increase surface skin cell turnover.

The Skin Activator Hydrating & Firming Line includes:

• Cetaphil Hydrating & Firming Cream for Neck, Chest, and Face (3.4 oz.)
• Cetaphil Hydrating & Firming Cream for Body (12 oz.)
• Cetaphil Hydrating & Firming Lotion (16 oz.)

In clinical trials, the Skin Activator Hydrating & Firming Lotion was effective in improving the appearance of skin crepiness and smoothing skin’s texture in one week. It also boosted hydration for firmer-looking skin in four weeks. Moreover, when patients were asked about their experiences, 88% of Skin Activator Hydrating & Firming Cream users said their skin looked less crepey in two days, and 87% said their skin appeared more youthful after one week, the Company reports.

A Turning Point

“This launch signals a turning point in how we approach skin longevity. It’s more fundamental than wrinkles or loss of firmness; it’s about preserving surface skin health at the cellular level,” says Alan D. Widgerow, MBBCh, MMed, FCS, FACS, Chief Scientific Officer of Galderma, in a news release. “As skin undergoes changes with age, it demands more precise, science-driven support. This insight fueled the development of our Skin Activator Hydrating & Firming line: a dermatologist-developed routine designed to strengthen, revitalize, and transform skin’s appearance.”

“As a dermatologist, I’m always looking for what’s next in skin science, especially when it comes to aging. That’s why I was so excited to work with Cetaphil on the Skin Activator Hydrating & Firming line,” explains Glynis R. Ablon, MD, director of the Ablon Skin Institute & Research Center in Manhattan Beach, California, and Associate Clinical Professor at UCLA. “We took on one of the biggest underlying causes of visible aging: surface skin health and cell senescence. By targeting these ‘zombie cells,’ we’re helping to support skin renewal in a way that’s truly backed by science. It’’ been incredibly rewarding to help bring that kind of innovation to a skincare routine patients can use all over, every day.”